The First Thirty
Venture capitalInactiveLondon · Seed–Series A · 17 people tracked
This fund appears to be inactive.
UK Companies House records show FIRST THIRTY LTD (no. 14129757) as dissolved. It is unlikely to be making new investments — this profile is kept for reference and historical accuracy.
Investment thesis
The First Thirty backs companies applying deeptech and physical AI to human longevity and healthspan. Its thesis centers on new technologies that make biological quality measurable at the soil, plant and animal level, and that link this quality to nutrition, verify it, and carry it through the supply chain. When buyers can procure against biological quality, demand for health becomes an economic signal back to agriculture, shifting value toward nutrition and biological outcomes rather than only yield, uniformity and shelf life. The firm invests across the measurement, intervention, verification and data infrastructure enabling this, targeting the large healthspan opportunity driven largely by prevention.
Source: firm website, verified Aug 3, 2026.
Team · 17 people
from the firm's website & curated & public directoriesWhat they invest in
from 5 of 6 portfolio companiesAgTech ×3AI & Machine Learning ×2Biotech ×2FoodTech ×2SaaS ×2Cleantech ×1Climate Tech ×1Defense Tech ×1
HQs:United Kingdom×1United States×1
Investments · 6 tracked
founders shown can be your intro pathAntler Bio develops RNA data analysis technology for dairy farmers, revealing gene expression patterns in farm animals to improve health, productivity and decision-making.
AgTechAI & Machine LearningBiotech
Co-investorsEndgame Capital
Edacious offers accredited lab testing and software for nutrient density analysis, helping food and agriculture organizations measure food quality, safety, and variability.
AgTechFoodTechSaaSMarlborough, US
Eric J. Smith(Executive Officer, Director)
BoardKevin Tidwell(Director)Asha Agrawal(Became a director following initial closing of financing.)
Co-investorsiSelect Fund
Co-investorsAcario InnovationClean Energy VenturesGENIUS Venture CapitalKintetsu Venture PartnersVolvo Group Venture Capital AB
Rhizocore Technologies develops mycorrhizal fungal inoculum products to enhance plant growth, woodland restoration, and ecosystem resilience.
AgTechBiotechCleantechClimate TechImpact & Social GoodEdinburgh, GB
Toby Parkes(Founder)inToby Philip Parkes(Director)David Christopher Satori(Director)Jack Hooper(Chief Operating Officer)
BoardDaniel Fitzgerald(Director)
Co-investorsCollaborative FundDeep Science VenturesGrosvenor EstateOld College CapitalScottish Enterprise
Portfolio news
latest coverage across their companiesRhizocore · globenewswire.com · Nov 19, 2025
Principals & officers · per Companies House
what is this? ⓘDirector · British · since 2022
Director · British · since 2022
Philip Anthony Curtis — 75–100% of shares, 75–100% of voting rights, right to appoint and remove directors
Frequently asked questions
- How many investments has The First Thirty made?
- The First Thirty has 6 tracked investments.
- What stage does The First Thirty invest at?
- The First Thirty invests at the Seed, Series A stages.
- What sectors does The First Thirty focus on?
- The First Thirty focuses on AgTech, AI & Machine Learning, Biotech, Cleantech, Climate Tech, Data & Infrastructure, Deep Tech, FoodTech, Healthtech, Longevity.
- Where is The First Thirty located?
- The First Thirty is headquartered in London, GB.
- Who does The First Thirty co-invest with?
- The First Thirty most often shares deals with Acario Innovation, Clean Energy Ventures, Collaborative Fund, among 10 tracked co-investors.
Images
Similar investors
Everywhere Ventures is an early-stage venture firm, backed by a community of founders and operators as LPs, that writes early checks (including pre-seed) into startups across many sectors and geographies.
Unruly Capital is a venture firm that backs founders working on ideas that seem too early or unconventional but are expected to become mainstream within a decade, focusing on frontier technology themes.
Khosla Ventures is a venture capital firm founded by Vinod Khosla.
Sofinnova Partners is a life sciences venture capital firm investing across the value chain from seed to later stage, with a focus on healthcare and sustainability. It backs companies in biopharma, medtech, digital medicine, agriculture and industrial processes.
Future Ventures is an early-stage venture capital firm backing mission-driven founders working on frontier and disruptive technologies aimed at reinventing entire industries.








